CBIO

Crescent Biopharma Inc

17.32

+0.63+3.77%

After Hours: 17.32 0.00 0.00%16:10 08/19 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE17.14/16.69

TODAY RANGE16.59-17.50

VOL170.24K

MARKET CAP643.33M

52 WEEK RANGE8.72-27.41

AVG VOL (3M)333.06K

% TURNOVER0.46%

TURNOVER--

P/E (TTM)-2.3372

% RANGE5.42%

EPS(TTM)-7.4105

P/E(FORWARD)-8.6600

P/B2.945

BVPS5.88

DIVIDEND--

P/S44.02

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP637.80M

SHARES OUTSTANDING37.14M

NEXT EARNINGS11/04-11/09

FREE FLOAT36.82M

LOT SIZE1

EX-DATE06/16/2025

News

Press Releases

Financial Reports

Profile

TipRanks·08/04 02:10
Analysts Offer Insights on Healthcare Companies: Dyne Therapeutics (DYN) and Crescent Biopharma (CBIO)
TipRanks·07/31 15:48
Crescent Biopharma (CBIO) Gets a Buy from Wedbush
TipRanks·07/31 10:30
Analysts Offer Insights on Healthcare Companies: Pasithea Therapeutics Corp (KTTA), Crescent Biopharma (CBIO) and Dexcom (DXCM)
TipRanks·07/30 20:35
Analyst Backs Crescent Biopharma With Buy Rating on Advancing ADC Pipeline and Strong Cash Runway
TipRanks·07/30 12:00
Crescent Biopharma reports Q2 EPS (74c), consensus (64c)
Dow Jones·07/30 11:35
*Crescent Biopharma 2Q Research and Development Expenses $19.4M >CBIO
Dow Jones·07/30 11:35
*Crescent Biopharma 2Q Loss/Shr 74c >CBIO
Dow Jones·07/30 11:35
Press Release: Crescent Biopharma Reports Second Quarter 2026 Financial Results and Recent Business Highlights
Dow Jones·07/30 11:35
Press Release: Crescent Biopharma Reports Second -2-
TipRanks·07/25 13:01
Travelers, TransDigm, Cytokinetics, Global-e, Crescent Shock Moves
TipRanks·07/22 12:30
Fourteen new option listings and one option delisting on July 22nd
TipRanks·07/21 02:01
Major Investor Makes Bold Move on Crescent Biopharma Shares
Dow Jones·07/16 20:01
Press Release: Crescent Biopharma Announces Closing of Public Offering of Ordinary Shares and Pre-Funded Warrants, Including Full Exercise of Underwriters' Option to Purchase Additional Shares
TipRanks·07/16 10:40
Analysts Offer Insights on Healthcare Companies: RxSight (RXST), Kazia Therapeutics (KZIA) and Crescent Biopharma (CBIO)
NASDAQ·07/15 09:17
Crescent Biopharma Prices $125 Mln Offering Of Shares And Pre-funded Warrants; Stock Down

Same Industry

Name/Symbol

Change%

Price

McKesson

MCK

-0.24%

866.93

Biogen Inc

BIIB

+1.63%

212.55

Amgen Inc

AMGN

-0.63%

415.21

SHPG

CELG-RT

Lilly Eli & Co

LLY

+0.25%

CELG

Therapeuticsmd Inc

TXMD

-0.48%

2.070

Johnson & Johnson

JNJ

+0.78%

262.37

ABBV

Zoetis Inc

ZTS

-2.70%

73.79

Gilead Sciences Inc

GILD

+0.16%

138.36

Novo-Nordisk A/S

NVO

-1.78%

45.89

Bristol-Myers Squibb Co

BMY

-1.27%

63.83

Alexion Pharms

ALXN

+1.70%

182.50

Pfizer

PFE

+0.30%

26.87

Sanofi FR

SNY

-0.14%

43.72

Sanofi FR

GCVRZ

0.00%

0.8711

Novartis

NVS

-0.55%

150.88

Dr Reddys Labs

RDY

-1.18%

12.13

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.